相关实验视频

Updated: Jan 13, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

儿童和青少年的脏瘤:一个回顾性,多中心队列研究

Katlyn G McKay¹, Catherine Beckhorn², Nelly-Ange T Kontchou¹

¹Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.

EClinicalMedicine

|January 9, 2026

概括

儿科肉瘤有很多种,其中脏清细胞肉瘤 (CCSK) 和尤文肉瘤 (EWS) 是最常见的. 存活率因类型和转移的存在而异,突显了对这些罕见的儿童癌症治疗标准化的挑战.

科学领域:

儿科瘤学儿科瘤学
肉瘤研究研究肉瘤研究
癌症基因组学癌症基因组学

背景情况:

儿科肉瘤是一种罕见的,组织学上多样化的,生物学上复杂的癌症.
标准化这些瘤的最佳疗法仍然是一个重大的临床挑战.
这项研究通过分析患者和疾病特征来解决知识差距.

研究的目的:

为了评估当前的患者,疾病和小儿瘤的生存特征.
识别知识缺口,以指导儿童肉瘤的未来研究和发现.
分析分子变化和转移模式对生存的影响.

主要方法:

对158名被诊断患有原发性肉瘤的患者 (≤21岁) 的回顾性分析 (2000-2022).
数据抽象包括人口统计,组织学,阶段和分子变化.
统计分析包括描述性统计,生存分析 (Kaplan-Meier) 和Cox回归.

主要成果:

脏清细胞肉瘤 (CCSK; n=94) 和尤宁肉瘤 (EWS; n=33) 是主要的亚型.
瘤类型与诊断时的年龄和整体存活时间 (OS) 有显著的相关性.
四年后的生存率从0.500 (狂宫肌肉瘤) 到0.927 (CCSK) 之间;转移的存在显著降低了生存率 (p=0.00015).

结论:

儿科肉瘤是一个异质的群体,具有不同的临床和分子形状.
治疗策略需要超越CCSK和EWS的亚型特定考虑.
对独特特征的进一步研究对于改善治疗结果至关重要.

关键词:

脏的无塑性肉瘤脏的无塑性肉瘤孩子孩子孩子孩子清晰细胞瘤的脏.DICER1 的意思是说.尤文肉瘤 (Ewing Sarcoma) 是一种癌症.脏肉瘤是一种脏肉瘤.

更多相关视频

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...